Seelos Therapeutics Receives FDA Fast Track Designation for Intranasal Racemic Ketamine (SLS-002)

    NEXT STORY
    RenovaCare Appoints Alan L. Rubino as President and CEO
    PREV STORY
    BioSig Technologies Welcomes the Creation of New Bioelectronic Medicine Alliance
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Contract Research Organizations (CROs) Market Worth $64.4 Billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research®

    author_avatar
    NASDAQ Market News

    CHMP recommends EU approval of Roche’s Tecentriq in combination with chemotherapy as an initial treatment of adults with extensive-stage small cell lung cancer

    author_avatar
    NASDAQ Market News

    Athenex Announces Participation in the 2020 RBC Capital Markets Global Healthcare Virtual Conference

    author_avatar
    NASDAQ Market News